Chesson Laboratory Associates, Inc.

Chesson Laboratory Associates, Inc. specializes in first aid absorbent pads and bandages, with a focus on liquid bandage formulations. These products are designed to protect and promote healing for minor wounds like cuts, burns, or abrasions by adhering to the skin and creating a moisture barrier. The company’s offerings fall under the category of wound care solutions.

The company is based in the United States. This location aligns with U.S. regulatory frameworks, including those governed by the FDA, which oversee the classification and listing of its devices.

Chesson Laboratory Associates, Inc.’s devices are classified as Class I under FDA regulations. This classification applies to products posing the lowest risk to patients, such as first aid absorbent pads and liquid bandages. Class I devices typically undergo 510(k) clearance (for non-exempt products) and must comply with the FDA’s Unique Device Identifier (UDI) system to ensure traceability and regulatory tracking.

Chesson Laboratory Associates, Inc.’s devices are listed in the FDA’s 510(k) database (for premarket submissions) and the FDA’s Unique Device Identifier (UDI) system. These registries ensure transparency in device authorization, compliance, and market tracking. The UDI system, in particular, helps identify and track devices throughout their lifecycle.

Liquid bandages from Chesson Laboratory Associates, Inc. are classified as Class I because they are intended for low-risk, non-invasive use on minor wounds. The FDA categorizes devices based on their potential risk to patients, and liquid bandages—while providing wound protection—do not involve significant surgical procedures, implants, or life-support functions. This classification simplifies regulatory oversight while ensuring basic safety and performance standards are met.